Chlamydia pneomoniae antibodies in chronic obstructive pulmonary disease

International Journal of Epidemiology

Volumn 25, Issue 3, 1996, Pages 658-664

  Von Hertzen, L ^a   Isoaho, R ^b   Leinonen, M ^a   Koskinen, R ^c   Laippala, P ^d   Toyryla M ^e   Kivela S L ^f   Saikku, P ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c Laakso Hospital   (Finland)

^d UNIVERSITY OF TAMPERE   (Finland)

^e Tampere University Hospital ^*  (Finland)

^f UNIVERSITY OF OULU   (Finland)

Author keywords

Aged; Chlamydia pneumoniae; Chronic disease; Chronic obstructive pulmonary disease; Serology

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; REGRESSION ANALYSIS; RISK; SEROLOGY; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED;

AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; ODDS RATIO;

EID: 0029666483     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/25.3.658     Document Type: Article

References (37)

1. Cohen B H, Ball W C Jr, Brashears S et al. Risk factors in chronic obstructive pulmonary disease (COPD). Am J Epidemiol 1977; 105: 223-31.
2. Higgins M W, Keller J B, Landis J R et al. Risk of chronic obstructive pulmonary disease. Collaborative assessment of the validity of the Tecumseh Index of Risk. Am Rev Respir Dis 1984; 130: 380-85.
3. Davis R M, Novotny T E. The epidemiology of cigarette smoking and its impact on chronic obstructive pulmonary disease. Am Rev Respir Dis 1989; 140: S82-S84.
4. Fletcher C, Peto R, Tinker C, Speizer F. The Natural History of Chronic Bronchitis and Emphysema. Oxford: Oxford University Press, 1976.
5. Linden M, Rasmussen J B, Piitulainen E et al. Airway inflammation in smokers with non-obstructive and obstructive chronic bronchitis. Am Rev Respir Dis 1993; 148: 1226-32.
6. Irvine D, Brooks A, Waller R. The role of air pollution, smoking and respiratory illnesses in childhood in the development of chronic bronchitis. Chest 1980; 77: 251-52.
7. Higgins M. Risk factors associated with chronic obstructive lung disease. Ann N Y Acad Sci 1991; 624: 7-17.
8. Barker D J, Osmond C. Childhood respiratory infection and adult chronic bronchitis in England and Wales. BMJ 1986; 293: 1271-75.
9. Tager I, Speizer F. Role of infection in chronic bronchitis. N Engl J Med 1975; 292: 563-71.
10. Gump D, Phillips B, Forsyth B, McIntosh K, Lamborn K, Stouch W. Role of infection in chronic bronchitis. Am Rev Respir Dis 1976; 113: 465-74.
11. Niewoehner D. The role of chronic bronchitis in the pathogenesis of chronic obstructive pulmonary disease. Semin Respir Infect 1988; 3: 14-26.
12. Grayston J T, Campbell L A, Kuo C C et al. A new respiratory tract pathogen: Chlamaydia pneumoniae strain TWAR. J Infect Dis 1990; 161: 618-25.
13. Chirgwin K, Roblin P, Gelling M, Hammerschlag MR, Schachter J. Infection with Chlamydia pneumoniae in Brooklyn. J Infect Dis 1991; 163: 757-61.
14. Hahn D L, Dodge R, Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis and adult-onset asthma. JAMA 1991; 266: 225-30.
15. Hammerschlag M R, Chirgwin K, Roblin P M et al. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis 1992; 141: 178-82.
16. Mårdh P A, Paavonen J, Puolakkainen M. Chlamydia. New York and London: Plenum Medical Book Co., 1989.
17. Grayston T J. Chlamydia pneumoniae, strain TWAR. Chest 1989; 95: 664-69.
18. Schachter J. Diagnosis of chronic chlamydial infections. In: Spencer RC et al. (eds). Rapid Methods and Automation in Microbiology and Immunology. London: Intercept, 1993, pp. 737-80.
19. Sarov I, Sarov B, Lunefeld E, Zion H, Chaim W, Piura B. The significance of Chlamydia specific serum IgA antibodies in Chlamydia trachomatis infections. In: Proceedings of the First Conference of the European Society for Chlamydia Research. Bologna: Societa Editrice Esculapio, 1988, pp. 234-37.
20. Saikku P. The epidemiology and significance of Chlamydia pneumoniae. J Infect 1992; 25(Suppl. 1): 27-34.
21. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144: 1202-18.
22. Rose G, Blackburn H, Gillum R, Prineas R. Cardiovascular Survey Methods. World Health Organization Monograph Series No. 56. Geneva: World Health Organization, 1982.
23. Isoaho R, Puolijoki H, Huhti E, Kivelä S-L, Laippala P, Tala E. Prevalence of chronic obstructive pulmonary disease in elderly Finns. Respir Med 1994; 88: 571-80.
24. Medical Research Council. Questionnaire on Respiratory Symptoms (1986). London: MRC, 1986.
25. Wang SP, Grayston J T. Immunologic relationship between genital TRIC, lymphogranuloma venereum and related organisms in a new microtiter indirect immunofluorescence test. Am J Ophthalmol 1970; 70: 367-74.
26. Ekman M R, Leinonen M, Syrjälä H, Linnanmäki E, Kujala P, Saikku P. Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae pneumonia during an epidemic in Finland. Eur J Clin Microbiol Infect Dis 1993; 12: 756-60.
27. Nurminen M, Leinonen M, Saikku P, Mäkelä P H. The genus-specific antigen of Chlamydia: Resemblance to the lipopolysaccharide of enteric bacteria. Science 1983; 220: 1279-81.
28. Hammerschlag M R. Chlamydia pneumoniae infections (letter). Ped Infect Dis J 1993; 12: 260-61.
29. Karvonen M, Tuomilehlo J, Pitkäniemi J, Saikku P. The epidemic cycle of Chlamydia pneumoniae infection in eastern Finland, 1972-1987. Epidemiol Infect 1993; 110: 349-60.
30. Saikku P, Leinonen M, Tenkanen L et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Int Med 1992; 116: 273-78.
31. Brett M M, Ghoneim A T M, Littlewood J M. Serum IgA antibodies against Pseudomonas aeruginosa in cystic fibrosis. Arch Dis Child 1990; 65: 259-63.
32. Jones JG, Lawler P, Crawley JC, Minty BD, Hulands G, Veall N. Increased alveolar epithelial permeability in cigarette smokers. Lancet 1980; i: 66-68.
33. Pomerleau O F, Pomerleau C S. Cortisol response to a psychological stressor and/or nicotine. Pharmacol Biochem Behavior 1990; 36: 211-13.
34. Rook G A W, Hernandez-Pando R, Lightman S L. Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance. Immunol Today 1994; 15: 301-03.
35. Holland M J, Bailey R I, Hayes L J, Whittle H C, Mabey D C W. Conjunctival scarring in trachoma is associated with depressed cell-mediated immune response to chlamydial antigens. J Infect Dis 1993; 168: 1528-31.
36. Beaty C, Grayston T, Wang S, Kuo C, Reto C, Martin T. Chlamydia pneumoniae, strain TWAR. infection in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1991; 144: 1408-10.
37. Blasi F, Legnani D, Lombarde V et al. Chlamydia pneumoniae infection in acute exacerbations of COPD. Eur Respir J 1993; 6: 19-22.